Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

3.05
Delayed Data
As of Feb 17
 +0.10 / +3.39%
Today’s Change
1.77
Today|||52-Week Range
6.69
+1.67%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.95
Today’s open2.90
Day’s range2.80 - 3.05
Volume878,471
Average volume (3 months)1,361,100
Market cap$97.3M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+56.50%
Earnings growth (this year)+7.22%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+77.69%
P/E ratioNM
Price/Sales1.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRMECardiome Pharma Corp0.000.00%
PRQRProQR Therapeutics N...+0.10+2.41%
CPRXCatalyst Pharmaceuti...+0.03+2.68%
EIGREiger BioPharmaceuti...+0.15+1.34%
Data as of 3:59pm ET, 02/17/2017

Financials

Next reporting dateMarch 13, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$51.2M
Annual profit (last year)-$16.3M
Net profit margin-31.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs